In this week's newsletter, also read about Ameera Shah, executive chairperson of Metropolis Healthcare's views on gender ...

The applicant (Danny Gaekwad Developments & Investments, Florida) has failed to demonstrate his ability to meet the financial ...

Gaekwad had requested Sebi's exemption under takeover rules to propose ₹275 a share for Religare, offering a 17% premium to ...

SEBI rejects Gaekwad's plea for competing open offer, solidifying Burman Group's acquisition bid for Religare Enterprises.

The Securities and Exchange Board of India (SEBI) on Friday rejected a request from US-based businessman Danny Gaekwad to ...

Sebi rejects Danny Gaekwad's application for competing open offer for Religare Enterprises, citing lack of financial proof.

In order to protect the interests of the shareholders of the target company, Bhatia disposed of the February 1 application of ...

Sebi rejected Digvijay Gaekwad's competing open offer for Religare Enterprises, citing lack of financial ability and ...

Regulator says application 'frivolous', not backed by financial capabilities; also questions due diligence of investment ...

The Securities and Exchange Board of India (SEBI) has denied an exemption request from Digvijay Laxhamsinh Gaekwad (Danny ...

Sebi has ruled that Gaekwad’s competing bid for Religare was not financially credible and violated regulatory timelines, ...